SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001171843-20-008661
Filing Date
2020-12-21
Accepted
2020-12-21 09:00:23
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_122120.htm 425 73843
2 EXHIBIT 2.1 exh_21.htm EX-2.1 734186
3 EXHIBIT 2.2 exh_22.htm EX-2.2 98854
4 EXHIBIT 4.1 exh_41.htm EX-4.1 154488
5 EXHIBIT 4.2 exh_42.htm EX-4.2 155743
6 EXHIBIT 4.3 exh_43.htm EX-4.3 149505
7 EXHIBIT 10.1 exh_101.htm EX-10.1 67873
8 EXHIBIT 10.2 exh_102.htm EX-10.2 58984
9 EXHIBIT 10.3 exh_103.htm EX-10.3 23630
10 EXHIBIT 10.4 exh_104.htm EX-10.4 19606
11 EXHIBIT 10.5 exh_105.htm EX-10.5 260058
12 EXHIBIT 10.6 exh_106.htm EX-10.6 394331
13 EXHIBIT 10.7 exh_107.htm EX-10.7 18393
  Complete submission text file 0001171843-20-008661.txt   2211302
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filed by) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Subject) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33672 | Film No.: 201402566
SIC: 2836 Biological Products, (No Diagnostic Substances)